Premium
Psychedelic‐assisted therapy considered ‘breakthrough’ treatment for PTSD
Author(s) -
Canady Valerie A.
Publication year - 2021
Publication title -
mental health weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7583
pISSN - 1058-1103
DOI - 10.1002/mhw.32791
Subject(s) - food and drug administration , multidisciplinary approach , medicine , psychotherapist , posttraumatic stress , psychiatry , psychology , pharmacology , social science , sociology
New research involving the use of psychedelic‐assisted therapy is showing promise and significant implications for patients with severe, chronic post‐traumatic stress disorder (PTSD) and could potentially move the needle further toward Food and Drug Administration (FDA) approval, say researchers from the Multidisciplinary Association for Psychedelic Studies (MAPS).